GB989077A - Stable oral poliomyelitis vaccines and process for preparing them - Google Patents

Stable oral poliomyelitis vaccines and process for preparing them

Info

Publication number
GB989077A
GB989077A GB46116/61A GB4611661A GB989077A GB 989077 A GB989077 A GB 989077A GB 46116/61 A GB46116/61 A GB 46116/61A GB 4611661 A GB4611661 A GB 4611661A GB 989077 A GB989077 A GB 989077A
Authority
GB
United Kingdom
Prior art keywords
carrier
preparing
kernels
drying
types
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB46116/61A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of GB989077A publication Critical patent/GB989077A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/13Poliovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
GB46116/61A 1961-08-16 1961-12-22 Stable oral poliomyelitis vaccines and process for preparing them Expired GB989077A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB63662A DE1157734B (de) 1961-08-16 1961-08-16 Verfahren zur Herstellung von haltbaren, oral zu verabreichenden Poliomyelitisvirus-Praeparaten

Publications (1)

Publication Number Publication Date
GB989077A true GB989077A (en) 1965-04-14

Family

ID=6974088

Family Applications (1)

Application Number Title Priority Date Filing Date
GB46116/61A Expired GB989077A (en) 1961-08-16 1961-12-22 Stable oral poliomyelitis vaccines and process for preparing them

Country Status (6)

Country Link
DE (1) DE1157734B (de)
FI (1) FI40401B (de)
FR (1) FR2084M (de)
GB (1) GB989077A (de)
LU (1) LU40963A1 (de)
SE (1) SE303173B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039399A1 (en) * 2002-11-01 2004-05-13 Glaxosmithkline Biologicals S.A. Immunogenic composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2966443A (en) * 1959-06-22 1960-12-27 American Cyanamid Co Trivalent poliomyelitis live virus vaccine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039399A1 (en) * 2002-11-01 2004-05-13 Glaxosmithkline Biologicals S.A. Immunogenic composition
US8409587B2 (en) 2002-11-01 2013-04-02 Glaxosmithkline Biologicals S.A. Immunogenic composition

Also Published As

Publication number Publication date
SE303173B (de) 1968-08-19
FR2084M (de) 1963-10-21
LU40963A1 (de) 1962-02-15
DE1157734B (de) 1963-11-21
FI40401B (de) 1968-09-30

Similar Documents

Publication Publication Date Title
SE8104661L (sv) Stabil mikrokristallin form av cisplatin, forfarande for framstellning derav samt stabil, steril torrblandningsberedning derav
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
GB989077A (en) Stable oral poliomyelitis vaccines and process for preparing them
Kara et al. 9-(S)-(2, 3-Dihydroxypropyl) adenine inhibits the transformation of chick embryo fibroblasts infected with Rous sarcoma virus: Evidence for inhibition of enzymatic activity of isolated cellular protein kinases by the drug
GB595552A (en) Improvements in or relating to processes of treating starch to render it substantially free of thermophilic bacteria
JPS51118820A (en) A process for preparing heat stable macroglobulin
JPS55162981A (en) Preparation of solid koji (malted rice)
GB806949A (en) Production of pharmaceutical preparations
Svet-Moldavsky The pathogenicity of Rous sarcoma virus for mammals; multiple cysts and haemorrhagic lesions of internal organs in white rats after inoculation with Rous virus during the embryonic or newborn period
GB1012918A (en) Process for preparing sodium cyanide
GB918055A (en) Process for the preparation of 3-(2-ethyl-2-nitrovinyl) indole
FR2143588A1 (en) Goose hepatitis live vaccine - for active immunization of water fowl
FR1146112A (fr) Procédé de préparation d'acide chlorhydrique gazeux sec sous pression à partir d'acide chlorhydrique aqueux concentré
JPS57125655A (en) Steaming of green tea manufacture and its device
NL175523C (nl) Werkwijze voor het winnen van guanidinecarbonaat.
GB226847A (en) Improvements in and relating to the manufacture of tobacco
GB876846A (en) Process and apparatus for the disinfection of sewage
ZA796944B (en) Vaccines against diseases,caused by reovirus,and process for the preparation of those vaccines
GB821883A (en) Method for the production of dry cereal gruel preparations
JPS527500A (en) Apparatus for drying tobacco leaves
JPS56115724A (en) Prophilaxis and remedy for avian infectious coryza
JPS51149658A (en) Machine hand to transfer parts
GB825012A (en) Improvements in or relating to the production of organotherapeutical preparations
JPS51131458A (en) A process for treatment of high temperature high pressure exhaust gas
GB738454A (en) Improvements in or relating to the production of poliomyelitis virus vaccine